Provention Bio to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Rhea-AI Summary

Provention Bio, Inc. (Nasdaq: PRVB) announced its participation in a fireside chat at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on September 22, 2021, at 9:05 AM E.T. The event will be webcast live and available for 30 days on the company's website. Provention Bio is committed to developing therapies to intercept and prevent immune-mediated diseases, with a pipeline targeting autoimmune conditions like type 1 diabetes and lupus. For more updates, visit www.ProventionBio.com.

RED BANK, N.J., Sept. 16, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on Wednesday, September 22, 2021 at 9:05 am E.T.

The presentation will be webcast live and can be accessed by visiting the Events and Webcasts section of the Company's website: http://investors.proventionbio.com/events. The webcast will be archived on the Company's website for 30 days following the presentation.

About Provention Bio, Inc.:

Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company's pipeline includes clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in autoimmune diseases, including type 1 diabetes, celiac disease and lupus. Visit www.ProventionBio.com for more information and follow us on Twitter: @ProventionBio.

Internet Posting of Information:

Provention Bio, Inc. uses its website, www.proventionbio.com, as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation F.D. Such disclosures will be included on the Company's website in the "News" section. Accordingly, investors should monitor this portion of the Company's website, in addition to following its press releases, SEC filings and public conference calls and webcasts.

Investor Contacts:

Robert Doody, VP of Investor Relations
rdoody@proventionbio.com
484-639-7235

Sam Martin, Argot Partners
proventionbio@argotpartners.com   
212-600-1902

Media Contact:

Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808

View original content to download multimedia:https://www.prnewswire.com/news-releases/provention-bio-to-present-at-the-oppenheimer-fall-healthcare-life-sciences-and-medtech-summit-301377988.html

SOURCE Provention Bio, Inc.

FAQ

When is Provention Bio's presentation at the Oppenheimer Summit?

Provention Bio will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on September 22, 2021, at 9:05 AM E.T.

Where can I watch Provention Bio's presentation?

The presentation can be watched live via the Events and Webcasts section of Provention Bio's website.

What is the focus of Provention Bio?

Provention Bio focuses on developing therapies that intercept and prevent immune-mediated diseases, including type 1 diabetes and lupus.

What stock symbol represents Provention Bio?

Provention Bio is represented by the stock symbol PRVB.